1. Home
  2. >Research
  3. >Ttn Truncating Variants In Cardiac Expressed Exons Show High Penetrance For Cardiomyopathy In Carriers With Atrial Fibrillation
Skip to main content
Research

TTN truncating variants in cardiac-expressed exons show high penetrance for cardiomyopathy in carriers with atrial fibrillation

October 26, 2022Helix Partners

Ready to see the whole picture?

Connect with our team to discover how Helix can transform your approach to genomic medicine.

TTN truncating variants in cardiac-expressed exons show high penetrance for cardiomyopathy in carriers with atrial fibrillation | Helix